Hind.Bio Science

Market Cap: Micro Cap
Industry: Software Products
ISIN: INE597C01021
NSEID:
BSEID: 532041
View on BSE

INR

9.40

0.44 (4.91%)

BSENSE

Feb 11

BSE+NSE Vol: 30.81 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nihar Info Glob.

CLIO Infotech

Hind.Bio Science

Indo-City Info.

First Fintec

Infronics Sys.

Groarc Industrie

Hit Kit Global

Kati Patang PP

Svam Software

Omni Ax's

Why is Hindustan Bio Sciences Ltd ?

Weak Long Term Fundamental Strength with a -0.40% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
The company has been able to generate a Return on Equity (avg) of 8.60% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

NO KEY NEGATIVE TRIGGERS

With ROCE of -0.3, it has a Very Expensive valuation with a 3.5 Enterprise value to Capital Employed

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 10.59%, its profits have risen by 4% ; the PEG ratio of the company is 1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Software Products)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hind.Bio Science for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Hind.Bio Science

10.59%

0.19

56.88%

Sensex

10.41%

0.90

11.52%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-16.00%

EBIT Growth (5y)

-0.40%

EBIT to Interest (avg)

-0.10

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

2.60

Sales to Capital Employed (avg)

0.26

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-9.11%

ROE (avg)

8.60%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.64

EV to EBIT

12.24

EV to EBITDA

12.24

EV to Capital Employed

3.54

EV to Sales

11.33

PEG Ratio

1.03

Dividend Yield

ROCE (Latest)

-0.29%

ROE (Latest)

14.00%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...